B. von Graffenried
- Genetics top 5%
- Surgery top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Immunology
- Molecular Biology
- Co-authors
- C. R. StillerJohn DupréM. JennerB. M. WolfeR. MartellN. W. RodgerPaul KeownAndreas Laupacis
- Topics
- Pain Mechanisms and Treatments (3 papers)Diabetes and associated disorders (3 papers)Pancreatic function and diabetes (3 papers)
- Journals
- NatureScienceThe Lancet
In The Last Decade
B. von Graffenried
20 papers receiving 860 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Genetics 369
- Surgery 358
- Endocrinology, Diabetes and Metabolism 348
- Immunology 176
- Molecular Biology 144
Countries citing papers authored by B. von Graffenried
This map shows the geographic impact of B. von Graffenried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. von Graffenried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. von Graffenried more than expected).
Fields of papers citing papers by B. von Graffenried
This network shows the impact of papers produced by B. von Graffenried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. von Graffenried. The network helps show where B. von Graffenried may publish in the future.
Co-authorship network of co-authors of B. von Graffenried
This figure shows the co-authorship network connecting the top 25 collaborators of B. von Graffenried. A scholar is included among the top collaborators of B. von Graffenried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. von Graffenried. B. von Graffenried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Pharmacology and Therapeutic Use in Autoimmune Diseases | 2 |
| 2 | Safety and tolerability of cyclosporin A (Sandimmun®) in idiopathic nephrotic syndrome | 12 |
| 3 | 46 | |
| 4 | Pharmacology of cyclosporin A (Sandimmun) and clinical experience in inflammatory bowel diseases. | 10 |
| 5 | 64 | |
| 6 | 53 | |
| 7 | 4 | |
| 8 | 36 | |
| 9 | Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onsetbreakdown → | 428 |
| 10 | 18 | |
| 11 | Antipyretic activity of fluproquazone in man. | 5 |
| 12 | 19 | |
| 13 | 5 | |
| 14 | 20 | |
| 15 | 31 | |
| 16 | 11 | |
| 17 | Effets compétitifs du pindolol et du salbutamol sur la résistance des voies aériennes chez les asthmatiques. | 2 |
| 18 | 2 | |
| 19 | 117 | |
| 20 | 60 |
About B. von Graffenried
B. von Graffenried is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Behavioral Neuroscience, having authored 20 papers that have together received 945 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (3 papers), Diabetes and associated disorders (3 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (348 citations), Transplantation (41 citations) and Genetics (369 citations). B. von Graffenried has collaborated with scholars based in Japan, Canada and Australia. Frequent co-authors include C. R. Stiller, John Dupré, M. Jenner, B. M. Wolfe, R. Martell, N. W. Rodger, Paul Keown, Andreas Laupacis, Michael Gent and G Feutren. Their work appears in journals such as Nature, Science and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.